News
Investor's Business Daily on MSN
IBD Rating Upgrades: AtriCure Flashes Improved Price Strength
AtriCure holds the No. 7 rank among its peers in the Medical-Systems/Equipment industry group. Brainsway ADR BWAY, iRadimed ...
Investor's Business Daily on MSN
Kymera Therapeutics Sees IBD RS Rating Rise To 71
Over 100 years of market history reveals that the best-performing stocks tend to have an RS Rating of at least 80 as they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback